Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ABTL0812 |
Trade Name | |
Synonyms | ABTL-0812 |
Drug Descriptions |
ABTL0812 is a lipid analog that inhibits mTOR and DHFR, potentially resulting in decreased tumor cell proliferation and increased tumor cell death (Cancer Res April 15, 2012 72:922, PMID: 32397857). |
DrugClasses | mTOR Inhibitor 51 |
CAS Registry Number | 57818-44-7 |
NCIT ID | C117290 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ABTL0812 | ABTL0812 | 0 | 0 |
ABTL0812 + Fluorouracil + Irinotecan + Oxaliplatin | ABTL0812 Fluorouracil Irinotecan Oxaliplatin | 0 | 1 |